The Maternal Pertussis Randomised Control Trial: best practice for the communication of pertussis booster vaccine recommendations to new mothers.
Not Applicable
Recruiting
- Conditions
- PertussisPublic Health - Health promotion/educationReproductive Health and Childbirth - Childbirth and postnatal care
- Registration Number
- ACTRN12613000580774
- Lead Sponsor
- Associate Professor John Sinn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 1080
Inclusion Criteria
Postpartum women not up to date with pertussis booster recommendations ( dTpa <10 years)
Exclusion Criteria
Requires an interpreter.
Unable to given written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pertussis booster vaccine uptake by postpartum women, assessed by follow up questionnaire completed prior to discharge. [Immediate postpartum period (prior to discharge from hospital following childbirth).]
- Secondary Outcome Measures
Name Time Method Baseline attitude and other factors influencing vaccine uptake were assessed using a self-administered, web-based questionnaire completed on an Apple Ipad (Registered Trademark) at the participant's bedside. <br><br>The questionnaire was comprised of 5 parts structure according to the Health Belief Model framework, with questions on: a) pertussis vaccination information sources b) pertussis susceptibility and severity c) vaccine benefits and barriers d) intentions to be vaccinated and e) demographic information.[At baseline (following completion of the baseline questionnaire, prior to allocation of the intervention or control).];Additional follow up ( by preferred method of phone or email) to assess household pertussis vaccine status and household exposure to pertussis and/or epidsode/s of pertussis.[six months postpartum]